- ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
- Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response.
- Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.
- Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
- In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia.
- Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone.
